184 related articles for article (PubMed ID: 28603971)
1. Enhanced and Prolonged Cell-Penetrating Abilities of Arginine-Rich Peptides by Introducing Cyclic α,α-Disubstituted α-Amino Acids with Stapling.
Oba M; Kunitake M; Kato T; Ueda A; Tanaka M
Bioconjug Chem; 2017 Jul; 28(7):1801-1806. PubMed ID: 28603971
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of six-membered carbocyclic ring α,α-disubstituted amino acids and arginine-rich peptides to investigate the effect of ring size on the properties of the peptide.
Kato T; Kita Y; Iwanari K; Asano A; Oba M; Tanaka M; Doi M
Bioorg Med Chem; 2021 May; 38():116111. PubMed ID: 33838611
[TBL] [Abstract][Full Text] [Related]
3. Secondary structures and cell-penetrating abilities of arginine-rich peptide foldamers.
Oba M; Nagano Y; Kato T; Tanaka M
Sci Rep; 2019 Feb; 9(1):1349. PubMed ID: 30718681
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.
Kato T; Oba M; Nishida K; Tanaka M
Bioconjug Chem; 2014 Oct; 25(10):1761-8. PubMed ID: 25188671
[TBL] [Abstract][Full Text] [Related]
5. A Helix-Stabilized Cell-Penetrating Peptide as an Intracellular Delivery Tool.
Yamashita H; Oba M; Misawa T; Tanaka M; Hattori T; Naito M; Kurihara M; Demizu Y
Chembiochem; 2016 Jan; 17(2):137-40. PubMed ID: 26560998
[TBL] [Abstract][Full Text] [Related]
6. Effect of helicity and hydrophobicity on cell-penetrating ability of arginine-rich peptides.
Oba M; Nakajima S; Misao K; Yokoo H; Tanaka M
Bioorg Med Chem; 2023 Aug; 91():117409. PubMed ID: 37441862
[TBL] [Abstract][Full Text] [Related]
7. Cell-Penetrating Peptides Using Cyclic α,α-Disubstituted α-Amino Acids with Basic Functional Groups.
Kato T; Oba M; Nishida K; Tanaka M
ACS Biomater Sci Eng; 2018 Apr; 4(4):1368-1376. PubMed ID: 33418667
[TBL] [Abstract][Full Text] [Related]
8. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Kim S; Hyun S; Lee Y; Lee Y; Yu J
Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
[TBL] [Abstract][Full Text] [Related]
9. Development of helix-stabilized cell-penetrating peptides containing cationic α,α-disubstituted amino acids as helical promoters.
Yamashita H; Misawa T; Oba M; Tanaka M; Naito M; Kurihara M; Demizu Y
Bioorg Med Chem; 2017 Mar; 25(6):1846-1851. PubMed ID: 28190655
[TBL] [Abstract][Full Text] [Related]
10. The rational design of cell-penetrating peptides for application in delivery systems.
Kang Z; Ding G; Meng Z; Meng Q
Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.
Joseph SC; Blackman BA; Kelly ML; Phillips M; Beaury MW; Martinez I; Parronchi CJ; Bitsaktsis C; Blake AD; Sabatino D
J Pept Sci; 2014 Sep; 20(9):736-45. PubMed ID: 24931620
[TBL] [Abstract][Full Text] [Related]
13. Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.
Ichimizu S; Watanabe H; Maeda H; Hamasaki K; Nakamura Y; Chuang VTG; Kinoshita R; Nishida K; Tanaka R; Enoki Y; Ishima Y; Kuniyasu A; Kobashigawa Y; Morioka H; Futaki S; Otagiri M; Maruyama T
J Control Release; 2018 May; 277():23-34. PubMed ID: 29530390
[TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids.
Kato T; Yamashita H; Misawa T; Nishida K; Kurihara M; Tanaka M; Demizu Y; Oba M
Bioorg Med Chem; 2016 Jun; 24(12):2681-7. PubMed ID: 27132868
[TBL] [Abstract][Full Text] [Related]
15. [Peptide Foldamers: Structural Control and Cell-penetrating Ability].
Oba M
Yakugaku Zasshi; 2019; 139(4):599-608. PubMed ID: 30930395
[TBL] [Abstract][Full Text] [Related]
16. Stapled peptides for intracellular drug targets.
Verdine GL; Hilinski GJ
Methods Enzymol; 2012; 503():3-33. PubMed ID: 22230563
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
18. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
19. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
20. Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides.
Wolfe JM; Fadzen CM; Holden RL; Yao M; Hanson GJ; Pentelute BL
Angew Chem Int Ed Engl; 2018 Apr; 57(17):4756-4759. PubMed ID: 29479836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
